Ridgefield, Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. was not upfront about the risks of its blood thinner, Pradaxa, a federal jury found Wednesday evening before returning a $1.25 million award for the family of an 84-year-old woman who died of severe bleeding.
The nine-person jury in the Southern District of West Virginia, Huntington Division, found for the family of Betty Knight on the count of fraud, awarding $50,000 in medical expenses and $200,000 in pain and suffering. It also awarded the family $1 million in punitive damages. But jurors found for the company, which is headquartered in Germany, on the first four counts regarding adequacy of warning labels and warrant claims.
Boehringer said in a statement that it would appeal to the U.S. Court of Appeals for the Fourth Circuit in Richmond, Virginia.c
